Business Context and Reporting Period
Company: Natural Alternatives International, Inc. (NAI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2005 (Six months ended)
Business Overview: NAI provides private label contract manufacturing services for nutritional supplements. On December 5, 2005, the company acquired Real Health Laboratories, Inc. (RHL), a direct marketer of branded nutritional supplements, to diversify its revenue streams and expand distribution channels.
Key Financial Metrics
| Metric | Six Months Ended Dec 31, 2005 | Six Months Ended Dec 31, 2004 |
|---|---|---|
| Net Sales | $41.6 million | $44.3 million |
| Gross Profit | $8.2 million | $9.9 million |
| Gross Margin | 19.8% | 22.4% |
| Net Income | $0.9 million | $1.6 million |
| Diluted EPS | $0.13 | $0.25 |
| Operating Cash Flow | $3.6 million | $2.5 million |
| Total Debt (Outstanding) | $7.2 million | $3.8 million (June 30, 2005) |
| Cash and Equivalents | $2.2 million | $1.9 million (June 30, 2005) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6% year-over-year. Private label contract manufacturing sales dropped 8% due to lower volumes and pricing from key customers (NSA International and Mannatech) and the discontinuation of two customer relationships in March 2005.
- Profitability Compression: Net income fell 47% to $0.9 million. Gross margin decreased 2.6 percentage points, driven by a shift in sales mix toward lower-margin powder products, incremental overhead from facility expansions, and higher labor costs.
- Acquisition Impact: The acquisition of RHL added $0.5 million in sales and $0.1 million in operating income for the period. However, pro forma results (excluding one-time rebate impacts) showed a net loss for the quarter due to interest expense and amortization.
- Debt Increase: Total debt increased significantly to fund the RHL acquisition, rising from $3.8 million to $7.2 million. This included a new $3.8 million term loan.
- Tax Rate Increase: The effective tax rate rose to 37.7% from 31.0% following the expiration of a Swiss tax holiday for the European subsidiary (NAIE).
Guidance, Outlook, and Risks
- Strategic Outlook: Management expects to fill $11.1 million in purchase orders from two new contract manufacturing customers in the second half of fiscal 2006. The company aims to leverage the RHL acquisition to expand into direct-to-consumer and mass-market retail channels.
- Debt Covenants: As of December 31, 2005, NAI was not in compliance with its tangible net worth financial covenant (actual $19.9 million vs. required $20.0 million). The lender has agreed to waive this non-compliance for the period.
- Customer Concentration: The company remains highly dependent on two customers, who accounted for 80% of total net sales for the six-month period.
- Legal Contingency: A patent infringement lawsuit filed by Novogen Research Pty. Ltd. is pending. A settlement of $75,000 was proposed, but terms are still being negotiated.
- Market Risks: The company faces exposure to foreign currency fluctuations (Euro and Swiss Franc) and rising interest rates on its variable-rate debt.
Investor Verification Checklist
- Covenant Compliance: Verify the status of the tangible net worth covenant waiver and ensure no further breaches occur in subsequent quarters.
- Customer Concentration: Monitor the stability of relationships with the top two customers, which represent 80% of revenue.
- Acquisition Integration: Assess whether the RHL acquisition achieves projected cost synergies and revenue growth to offset the increased debt load and amortization expenses.
- Legal Resolution: Track the final resolution of the Novogen patent infringement claim to confirm the $75,000 settlement figure or potential for higher costs.
- Margin Recovery: Evaluate if the shift in sales mix and facility expansion costs are temporary or indicative of a structural decline in gross margins.